FREE SHIPPING ON ORDERS OVER $150

pharma news today obesity drugs glp-1 september 2025 Novo Nordisk cuts forecast amid slower sales GLP-1 RA prescription trends: January

$28.57

Quantity
- +
Description

Access Limitations Define Americas Weight-Loss Divide More than 22 states now report adult obesity rates above 35%, and in several, including Mississippi, Louisiana, and West Virginia, rates approach or exceed 40%

pharma news today obesity drugs glp-1 september 2025 Novo Nordisk cuts forecast amid slower sales GLP-1 RA prescription trends: January

Mancini SA, Angelo JL, Peckler Z, Philp FH, Farah KF

pharma news today obesity drugs glp-1 september 2025 Novo Nordisk cuts forecast amid slower sales GLP-1 RA prescription trends: January

In March, the company announced plans to cut 427 jobs from its US workforce

pharma news today obesity drugs glp-1 september 2025 Novo Nordisk cuts forecast amid slower sales GLP-1 RA prescription trends: January

What if semaglutide is not working either

pharma news today obesity drugs glp-1 september 2025 Novo Nordisk cuts forecast amid slower sales GLP-1 RA prescription trends: January

About 63.2% of participants on liraglutide achieved at least 5% body weight loss, and 33.1% achieved at least 10% loss

pharma news today obesity drugs glp-1 september 2025 Novo Nordisk cuts forecast amid slower sales GLP-1 RA prescription trends: January

You may also like

recommand products